MA (EU) Number 
EU/1/07/399/001 
EU/1/07/399/002 
EU/1/07/399/003 
EU/1/07/399/004 
EU/1/07/399/005 
EU/1/07/399/006 
(Invented) 
name 
Aerinaze 
Aerinaze 
Aerinaze 
Aerinaze 
Aerinaze 
Aerinaze 
Strength 
Pharmaceutical Form 
2.5 mg / 120 mg*  Modified-release tablet 
Modified-release tablet 
2.5 mg / 120 mg 
Modified-release tablet 
2.5 mg / 120 mg 
Modified-release tablet 
2.5 mg / 120 mg 
Modified-release tablet 
2.5 mg / 120 mg 
Modified-release tablet 
2.5 mg / 120 mg 
Route of 
Administration 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Immediate Packaging  Pack size 
blister (PCTFE/PVC/alu) 
blister (PCTFE/PVC/alu) 
blister (PCTFE/PVC/alu) 
blister (PCTFE/PVC/alu) 
blister (PCTFE/PVC/alu) 
blister (PCTFE/PVC/alu) 
2 tablets 
4 tablets 
7 tablets 
10 tablets 
14 tablets 
20 tablets 
âˆ— 2.5 mg desloratadine/120 mg pseudoephedrine sulphate 
1/1 
 
 
